Topical antibiotics used in dermatology: Efficiency, indications and adverse events;Antibiotiques locaux en dermatologie: Efficacite, indications, effets indesirables

Annales de Dermatologie et de Venereologie

Volumn 127, Issue 4, 2000, Pages 425-431

  Machet, L ^a   Wolkenstein, P ^b   Vaillant, L ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTULLE LUMIERE; BACITRACIN; CEBEMYXINE; CLINDAMYCIN; DALACINE T; ERYACNE; ERYTHROMYCIN; FRAMYCETIN; FUSIDATE SODIUM; KANAMYCIN; METRONIDAZOLE; MUPIDERM; NEOMYCIN; POLYFRA; POLYMYXIN; PRIMIXINE; PSEUDOMONIC ACID; ROSICED; ROZAGEL; STERIMYCINE; STIMYCINE; TETRACYCLINE; VIRGINIAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION PREVENTION; OTOTOXICITY; SKIN DISEASE;

ANTI-BACTERIAL AGENTS; HUMANS; SKIN DISEASES, BACTERIAL;

EID: 0033918047     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Noble WC. Topical and systemic antibiotics : is there a rationale? Semin Dermatol 1990;9: 250-4.
2. 10, 13 p.
3. Patchett I, Peacock K, Vaillant L. A multinational, multicentre, randomised double-bind comparison of fusidic acid lotion versus placebo in the treatment of acne vulgaris of the face. Eur J Clin Res 1996;8:87-96.
4. Pappa KA. The clinical development of mupirocin. J Am Acad Dermatol 1990;22:873-9.
5. Carruthers R. Prescribing antibiotics for impetigo. Drugs 1988;36:364-9.
6. Choutet P, Besnier JM. Les antibiotiques et les antiviraux. In : Lorette G, Vaillant L, eds. Traitements locaux en dermatologie. Paris : Doin, 1995:74-8.
7. Bork K, Braners J, Kresten M. Efficacy and safety of 2 p. 100 mupirocin ointment in the treatment of primary and secondary skin infections : an open multicentre trial. Br J Clin Pract 1989;43:284-8.
8. Eells LD, Mertz PM, Piovanetti Y, Pekoe GM, Eaglstein WH. Topical antibiotic treatment of impetigo with mupirocin. Arch Dermatol 1986; 122:1273-6.
9. Villiger JW, Robertson WD, Kanji K, Ah-Chan M, Fetherston J, Hague IK, et al. A comparison of the new topical antibiotic mupirocin (Bactroban) with oral antibiotics in the treatment of skin infections in general practice. Curr Med Res Opin 1986;10:339-45.
10. White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment of superficial skin infections in general practice. A comparaison of mupirocin with sodium fusidate. J Infect 1989; 18:221-9.
11. Hirschmann JV. Topical antibiotics in dermatology. Arch Dermatol 1998;124:1691-700.
12. Labeille B. Traitement des infections cutanées superficielles à pyogènes. Ann Dermatol Venereol 1997;124:567-70.
13. Machet L, Puissant A, Vaillant L et le Groupe Français d'Etude des Infections Cutanées. Essai comparatif multicentrique de l'acide fusidique comprimés versus la pristinamycine comprimés dans le traitement des infections cutanées. Nouv Dermatol 1994;13:520-4.
14. Gilbert M. Topical 2 p. 100 mupirocin versus 2 p. 100 fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 1989;20:1083-7.
15. Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxy. Arch Intern Med 1989;149:1258-62
16. Yu VL, Coetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986;315:91-6.
17. Ghadially R, MB, Ch B, Ramsay CA. Gentamicin : systemic exposure to a contact allergen. J Am Acad Dermatol 1988;19:428-30.
18. Assier-Bonnet H, Revuz J. La néomycine topique : risques et bénéfices. Plaidoyer pour un retrait. Ann Dermatol Venereol 1997;124:721-5.
19. Hamann K, Thorn P. Systemic or local treatment of erythrasma? A comparison between erythromycin and fucidin cream in general practice. Scand J Prim Health Care 1991;9:35-9.
20. Heid E, Cribier B, Koessler A. Les corynébactérioses cutanées. Ann Dermatol Venereol 1994; 121:855-9.
21. Leyden JJ. Mupirocin, a new topical antibiotic. J Am Acad Dermatol 1990;22:879-83.
22. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin. Br J Dermatol 1988;119:189-98.
23. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994;131:536-40.
24. Boyce ST, Holder IA. Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconst Surgery 1993;92:493-500.
25. Colsky A, Kirsner RS, Kerdel FA. Analysis of antibiotic suceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol 1998;134:1006-9.
26. Bonnetblanc JM. Traitement local. In : Ulcè res de jambes. Paris : Doin 1996:164-71.
27. Livingston DH, Cryer HG, Miller FB, Malangoni MA, Polk HC, Weiner LJ. A randomized prospective study of topical antimicrobial agents on skin grafts after thermal injury. Plast Reconstr Surg 1990;86:1059-64.
28. Haas AF, Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995;32:155-79.
29. Vowels BR, Feingold DS, Sloughfy C, Foglia AN, Konnikov N, Ordoukhanian E, et al. Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora. Antimicrob Agents Chemother 1996;40:2598-604.
30. Bencini PL, Galimberti M, Signorini M, Crosti C. Antibiotic prophylaxis of wound infections in skin surgery. Arch Dermatol 1991;127: 1357-60.
31. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg 1998;24:315-20.
32. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527-35.
33. Bellman B, Brandt FS, Holtmann M, Bebell WR. Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face. Successful treatment with minocycline, rifampin, and mupirocin ointment. Dermatol Surg 1998;24:279-82.
34. Dire DJ, Coppola M, Dwyer DA, Lorette JJ, Karr JL. Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-tissue wounds repaired in the ED. Acad Emerg Med 1995;2:4-10.
35. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter : effect of mupirocin ointment. J Am Soc Nephrol 1998;9:1085-92.
36. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemoth 1996;38:829-37.
37. Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998;134:679-83.
38. Mills OH Jr, Kligman AM. Topically applied erythromycin in rosacea. Arch Dermatol 1976; 112:553-4.
39. Angelini G, Vena GA, Meneghini CL. Allergic contact dermatitis to some medicaments. Contact Dermatitis 1985;12:263-9.
40. Wilson CL, Cameron J, Powell SM, Cherry G, Ryan TJ. High incidence of contact dermatitis in leg-ulcer patients. Implications for management. Clin Exp Dermatol 1991;16:250-3.
41. Fraki JE, Peltonen L, Hopsu-Havu VK. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis. 1979;5:97-100.
42. Zaki I, Shall L, Dalziel KL. Bacitracin : a significant sensitizer in leg ulcer patients? Contact Dermatitis 1994;31:92-4.
43. Reichert-Penetrat S, Barbaud A, Ehlinger-Martin A, Weber M, Schmutz JL. Intérêt d'un bilan dermato-allergologique dans la prise en charge des ulcères de jambes (359 cas). Ann Dermatol Venereol 1997;124 : S18.
44. Katz BE, Fisher AA. Bacitracin : a unique topical antibiotic sensitizer. J Am Acad Dermatol 1987;17:1016-24.
45. Zappi EG, Brancaccio RR. Allergic contact dermatitis from mupirocin ointment. J Am Acad Dermatol 1997;36:266.
46. Degreef H, Dooms-Goossens A. Patch testing with silver sulfadiazine cream. Contact Dermatitis 1985;12:33-7.
47. Baptista A, Barros MA. Contact dermatitis from sodium fusidate. Contact Dermatitis 1990; 23:186-7.
48. Valsecchi R, Pansera B, Reseghetti A. Contact allergy to erythromycin. Contact Dermatitis 1996;34:428.
49. Pillette M, Claudel JP, Muller C, Lorette G. Toxidermie à la pristinamycine après sensibilisation à la virginiamycine topique. Allergie et Immunologie 1990;22:197.
50. Goh CL. Contact sensitivity to topical antimicrobials. Contact Dermatitis 1989;21:166-71.
51. Samsoen M, Metz R, Melchior E, Foussereau J. Allergie croisée entre les antibiotiques aminosides. Ann Dermatol Venereol 1979;106:683-9.
52. Gette MT, Marks JG, Maloney ME. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 1992; 128:365-7.
53. Grosshans E. Les effets secondaires (irritations, allergies, mesures préventives). In : Lorette G, Vaillant L, eds. Traitements locaux en dermatologie. Paris : Doin 1995:28-34.
54. Goossens C, Sass U, Song M. Baboon syndrome. Dermatology 1997;194:421-2.
55. Fernandez-Redondo V, Casas L, Taboada M, Toribio J. Systemic contact dermatitis from erythromycin. Contact Dermatitis 1994;30:43-4.
56. Schechter JF, Wilkinson RD, Del Carpio J Anaphylaxis following the use of bacitracin ointment. Report of a case and review of the literature. Arch Dermatol 1984;120:909-11.
57. Heidemuller B. Ototoxicity of locally administered aminoglycoside antibiotics. Laryngorhinootologie 1994;73:331-7.
58. Harkaway KS, McGinley KJ, Foglia AN, Lee WL, Fried F, Shalita AR, et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin benzoyl peroxide and combination therapy. Br J Dermatol 1992;126:586-90.
59. Wilson AP, Gruneberg RN, Treasure T, Sturridge MF. The effect of antibiotic prophylaxis and topical antiseptics on the bacterial flora of the skin after cardiac surgery. J Hosp Infect 1987;10:58-66.
60. Bojar RA, Eady EA, Jones CE, Cunliffe WJ, Holland KT. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994;130:329-36.
61. Young LS, Hindler J. Aminoglycoside resistance : a worldwide perspective. Am J Med 1986;80:15-21.
62. Irish D, Eltringham I, Teall A, Pickett H, Farelly H, Reith S, et al. Control of an outbreack of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 1998;39:19-26.
63. Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker DN. All Wales surveillance of methicillin-resistant Staphylococcus aureus. The first year's result. J Hosp Infect 1999;41:173-9.
64. Chatfield C, O'Neill WA, Cooke RP, McGhee KJ, Issak M, Rahman M, Noble WC. Mupirocin-resistant Staphylococcus aureus in a specialist school population. J Hosp Infect 1994;26:273-8.
65. Moy JA, Caldwell-Brown D, Lin AN, Pappa KA, Carter DM. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. J Am Acad Dermatol 1990;22:893-5.